View Article

Abstract

Skin cancer is one of the most prevalent malignancies worldwide, often necessitating localized and targeted therapeutic approaches to minimize systemic side effects. This study focuses on the development and evaluation of a sprayable nano emulsion formulation co-loaded with 5-Fluorouracil (5-FU) and Tretinoin for enhanced topical treatment of skin cancer. 5-FU is a well-established chemotherapeutic agent that inhibits DNA synthesis, while Tretinoin promotes epidermal turnover and enhances drug penetration. The nano emulsion was formulated using isopropyl myristate as the oil phase, Tween 80 and Span 20 as surfactants, as a co-surfactant. A pseudo-ternary phase diagram was constructed to identify the optimal nano emulsion region. The resulting formulation was evaluated for droplet size, polydispersity index, zeta potential, pH, viscosity, spray ability, and thermodynamic stability. Ex vivo skin permeation studies were conducted using Franz diffusion cells, and cytotoxicity was assessed on melanoma cell lines using MTT assay. The optimized formulation exhibited a globule size of ~100 nm, low polydispersity index (<0.3), and suitable physicochemical characteristics for dermal application. Enhanced skin permeation, sustained drug release, and superior cytotoxic activity were observed compared to conventional cream formulations. The inclusion of Tretinoin significantly improved the penetration of 5-FU, demonstrating a synergistic effect. The study concludes that the sprayable nano emulsion system offers a promising and patient-friendly alternative for the localized treatment of skin cancer, with potential to improve therapeutic efficacy and minimize systemic toxicity.

Keywords

5-Fluorouracil (5-FU), Tretinoin, Chemotherapeutic Agents, Skin Penetration Enhancement, Cytotoxicity

Introduction

5-Fluorouracil (5-FU) is a widely used topical chemotherapeutic agent that acts by inhibiting thymidylate synthase, thereby interfering with DNA synthesis and leading to apoptosis in rapidly dividing cancer cells. However, its clinical utility is often limited by poor skin penetration, instability, and irritation at the site of application. Tretinoin, a derivative of vitamin A, is known to promote skin turnover, enhance permeability of active agents, and has shown synergistic effects when used in combination with other anticancer agents, including 5-FU. The use of nano emulsion -based drug delivery systems has emerged as a promising approach to overcome the limitations of conventional topical formulations. Nano emulsions, with droplet sizes in the Nano meter range (typically 20–200 nm), offer advantages such as increased drug solubility, enhanced skin permeation, controlled drug release, physical stability, and better cosmetic acceptability. Furthermore, incorporating such systems into a sprayable dosage form offers ease of application, uniform dosing, and improved patient compliance.

Nano emulsion: -

A nano emulsion is a thermodynamically or kinetically stable colloidal dispersion consisting of two immiscible liquids (typically oil and water), stabilized by surfactants and/or co-surfactants, with droplet sizes ranging from 20 to 200 nanometers. Unlike conventional emulsions, nano emulsions have ultra-small droplet sizes, which impart them with unique physicochemical and biological advantages, especially in pharmaceutical and cosmetic formulations.

Key Characteristics of Nano emulsions:

  1. Droplet Size: Typically, between 20–200 nm, leading to a transparent or slightly bluish appearance.
  2. High Surface Area: The small droplet size offers a large surface area for drug absorption.
  3. Thermodynamic/Kinetic Stability: Some nano emulsions are thermodynamically stable, while others are kinetically stable with high resistance to coalescence, creaming, or phase separation.
  4. Enhanced Solubility: Nano emulsions can solubilize poorly water-soluble drugs, increasing their bioavailability.
  5. Improved Skin Permeation: Their nanometric size and composition enhance drug permeation through the skin, making them ideal for topical and transdermal delivery.
  6. Controlled Release: They offer the possibility of sustained or controlled drug release at the site of action.

Components of a Nano emulsion:

  1. Oil Phase: Solubilizes lipophilic drugs (e.g., isopropyl myristate, castor oil).
  2. Aqueous Phase: Usually purified water.
  3. Surfactant: Stabilizes the emulsion by reducing interfacial tension (e.g., Tween 80).
  4. Co-surfactant: Enhances the flexibility of the surfactant film (e.g., Transcutol P, PEG 400).             

Reference

  1. Ferreira FR, Costa Nascimento LF, Rotta O. Risk factors for non melanoma skin cancer in Taubaté, Sao Paulo, Brazil: a case–con trol study. Rev Assoc Med Bras. 2011; 57:424–30.
  2. Harsh M. Text book of pathology, Published by Jaypee Brothers Medical Publishers (P) Ltd, Edition 3rd; 1998. p. 1009–1016.
  3. Taveira SF, Lopez RFV. Topical administration of anticancer drugs for skin cancer treatment. Intech Open Access Publisher; 2011.
  4. Beers M, Porter R, Jones T, Kaplan J, Berkwits M. The Merck manual of diagnosis and therapy. Whithouse Station: Merck Research Laboratories; 2006.
  5. Russo T, Kasper D, Fauci A. Harrison’s principles of internal medicine. New York: McGraw-Hill; 2005. p. 937–9.

Photo
Anjali Sahu
Corresponding author

Rungta Institute of Pharmaceutical Sciences

Photo
Aparna Tiwari
Co-author

Rungta Institute of Pharmaceutical Sciences

Photo
Ayushi Khadatkar
Co-author

Rungta Institute of Pharmaceutical Sciences

Photo
Sneha Singh
Co-author

Rungta Institute of Pharmaceutical Sciences

Photo
Rajesh Kumar Nema
Co-author

Rungta Institute of Pharmaceutical Sciences

Photo
Gyanesh Kumar Sahu
Co-author

Rungta Institute of Pharmaceutical Sciences

Aparna Tiwari, Ayushi Khadatkar, Sneha Singh, Anjali Sahu*, Rajesh Kumar Nema, Gyanesh Kumar Sahu, Development and Evaluation of Sprayable Nanoemulsion For Skin Cancer Using 5- Fluorouracil and Tretinoin, Int. J. Sci. R. Tech., 2025, 2 (6), 514-521. https://doi.org/10.5281/zenodo.15712250

More related articles
Enhancing Drug Delivery: Formulation and Evaluatio...
Sudarshan Mirgal, Dr. Bharat Tekade, Dr. Mohan Kale, ...
Future-Driven Pharmaceutical Manufacturing Process...
Sajanraj Kankariya, Jay Pardeshi, Vishal Bagrecha, Dr. Ganesh Bas...
Predicting Childbirth Modes: A Comparative Analysi...
Matheswari S., Meaga J., Nishani S., Vizhiyarasi S., ...
Fragment-Based Drug Discovery: Opportunities and Challenges in Pharmaceutical Ch...
Mohammad Javed, Sita Kumari, Kundan Raj Jajware, Somya Saurav, Rajasmita Bhadra, ...
Economic Valuation and Willingness-to-Pay for Ecotourism Resources in Old-Oyo Na...
Kolawole Farinloye, Samson Ojo, Ibukun Ayodele, Gbolagade Lameed, Funmilayo Oni, ...
Related Articles
Harnessing Herbal Ingredients for UV Protection: A Review of Natural Sunscreen F...
Shivaji Patel, Parmeshwer Sahu, Chumendra Sahu, Narendra Jhurri, Chandraprabha Dewangan, Anjali Sahu...
A Study on the Different Types of Biochar on the Geotechnical Behaviour of Local...
Dr. Pranab Jyoti Barman, Abhisek Gupta, Debasish Dutta, Deepjyoti Dutta, Jubli Jaman, Kangkana Gogoi...
Enhancing Drug Delivery: Formulation and Evaluation of Novel Effervescent Tablet...
Sudarshan Mirgal, Dr. Bharat Tekade, Dr. Mohan Kale, ...
More related articles
Enhancing Drug Delivery: Formulation and Evaluation of Novel Effervescent Tablet...
Sudarshan Mirgal, Dr. Bharat Tekade, Dr. Mohan Kale, ...
Future-Driven Pharmaceutical Manufacturing Process: Role of Automation, Instrume...
Sajanraj Kankariya, Jay Pardeshi, Vishal Bagrecha, Dr. Ganesh Basarkar, ...
Predicting Childbirth Modes: A Comparative Analysis of Machine Learning Algorith...
Matheswari S., Meaga J., Nishani S., Vizhiyarasi S., ...
Enhancing Drug Delivery: Formulation and Evaluation of Novel Effervescent Tablet...
Sudarshan Mirgal, Dr. Bharat Tekade, Dr. Mohan Kale, ...
Future-Driven Pharmaceutical Manufacturing Process: Role of Automation, Instrume...
Sajanraj Kankariya, Jay Pardeshi, Vishal Bagrecha, Dr. Ganesh Basarkar, ...
Predicting Childbirth Modes: A Comparative Analysis of Machine Learning Algorith...
Matheswari S., Meaga J., Nishani S., Vizhiyarasi S., ...